ARTICLE I. NAME, CHARACTER, AND PRINCIPAL OFFICE OF PARTNERSHIPLimited Partnership Agreement • December 30th, 1996 • Fleming Standish • Pharmaceutical preparations
Exhibit 7(e) PLEDGE AGREEMENT Pledgor: Forward Ventures III, L.P. Address: 10975 Torreyana Road, Suite 230 San Diego, California 92121 Date: December ___, 1996 THIS PLEDGE AGREEMENT ("Pledge Agreement"), dated the above date, is entered into at...Pledge Agreement • December 30th, 1996 • Fleming Standish • Pharmaceutical preparations
Exhibit 7(d) SILICON VALLEY BANK LOAN AND SECURITY AGREEMENT BORROWER: FORWARD VENTURES III, L.P. ADDRESS: 10975 TORREYANA ROAD, SUITE 230 SAN DIEGO, CA 92121 DATE: DECEMBER 19, 1996 THIS LOAN AND SECURITY AGREEMENT is entered into on the above date...Loan and Security Agreement • December 30th, 1996 • Fleming Standish • Pharmaceutical preparations • California
WITNESSETH:General Partnership Agreement • November 12th, 1996 • Fleming Standish • Pharmaceutical preparations
Exhibit 1 Agreement Relating to Joint Filing of Schedule 13-G In accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934, the undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock...Joint Filing Agreement • February 12th, 1999 • Fleming Standish • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934, the undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock of Corixa Corporation shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
Exhibit 7(a) AGREEMENT OF JOINT FILING The undersigned hereby agree that they are filing jointly pursuant to Rule 13d-1(f)(1) of the Securities Exchange Act of 1934, as amended, the Amendment No. 3 to Schedule 13D dated August 6, 1998 containing the...Joint Filing Agreement • August 6th, 1998 • Fleming Standish • Pharmaceutical preparations
The undersigned hereby agree that they are filing jointly pursuant to Rule 13d-1(f)(1) of the Securities Exchange Act of 1934, as amended, the Amendment No. 3 to Schedule 13D dated August 6, 1998 containing the information required by Schedule 13D for the shares of Common Stock of Triangle Pharmaceuticals, Inc. held by the undersigned individuals and which Amendment No. 3 to Schedule 13D amends the original Schedule 13D filed by the undersigned on November 12, 1996, as amended by Amendment No. 1 thereto filed on December 30, 1998 and as amended by Amendment No. 2 thereto filed on November 10, 1997.
AGREEMENT RELATING TO JOINT FILING OF SCHEDULE 13GJoint Filing Agreement • February 13th, 1998 • Fleming Standish • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934, the undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock of Corixa Corporation shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
Exhibit 7(d) CONTINGENT PURCHASE AGREEMENT THIS CONTINGENT PURCHASE AGREEMENT is made as of the 4th day of June, 1996, by and between Biotechvest L.P. ("Seller") and Forward III Associates, L.L.C. ("Buyer"). WHEREAS, Seller and Buyer are the general...Contingent Purchase Agreement • November 12th, 1996 • Fleming Standish • Pharmaceutical preparations • California
